Atlas Trials

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease

Clinical trial NCT05049525 · TERMINATED

Trial details

NCT number
NCT05049525
Sponsor
Montreal Heart Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's DiseaseInflammatory Bowel Diseases
Start date
2022-02-22
Primary completion
2024-02-28
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.